AzTrials
AzTrials

Medical KnowledgeNCT01992120

Utility of High-Fidelity Simulation In the Education and Assessment of Residents in the Recognition and Management of the Sepsis Syndrome

A study testing Debriefing of high-fidelity sepsis simulation scenarios in people with Medical Knowledge and Clinical Performance, run by NYU Langone Health at 1 site in United States.

Terminated

Stopped early. The study ended before it was planned to and will not resume.

Official record
Search all trials

Trial summary

The primary objective of the proposed study will be to determine if a multi-modality teaching curriculum utilizing high-fidelity simulation and didactic lecture will result in sustained improvement by internal medicine residents in written knowledge and clinical performance when compared to residents receiving a… Read more about this study

Who is it for?
Ages 20 to 60 yearsHealthy volunteers can take part
Conditions the study is for
Medical Knowledge, Clinical Performance
What is being tested?
Debriefing of high-fidelity sepsis simulation scenarios
Could I receive a placebo?
Yes, some participants may receive a placebo
How many people
40 participants
Where
1 siteUnited States
Study dates
Nov 2013to Jul 2014
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 20 to 60 years
  • All sexes
  • Healthy volunteers accepted
  • Adult

Who may be able to join

  • English-speaking internal medicine resident trainees

Who cannot join

  • Anyone not meeting inclusion criteria

Trial locations and contacts

1 site in 1 country.

United States1 site
  • VA Harbor Simulation Center

    New York, New York, 10010

Other trials in United States

About this study

The primary objective of the proposed study will be to determine if a multi-modality teaching curriculum utilizing high-fidelity simulation and didactic lecture will result in sustained improvement by internal medicine residents in written knowledge and clinical performance when compared to residents receiving a curriculum utilizing only didactic lecture. The investigators hypothesis is that the addition of high-fidelity simulation to a traditional didactic lecture curriculum will result in sustained and superior written knowledge and practical performance when compared to a group receiving only didactic lecture on the same topic. Specifically, the investigators will be assessing internal medicine resident knowledge and performance in the area of sepsis in the hospitalized patient, and will shape the investigators teaching curriculum around this focus.

Read the detailed description

This is a randomized prospective single-blinded pilot study. Residents from the internal medicine residency program will be assigned a unique number to de-identify them, and then randomized, stratified by post-graduate year (PGY) level, by random number generator to intervention and control groups. Only de-identified information will be used in subsequent analysis, and no individual results will be used. Residents will not know to which group they have been randomized.

Both the intervention and control groups will take a pre-course survey assessing their level of training, area of specialty/interest, and level of confidence in the recognition and management of sepsis.

Both the intervention and control groups will then be put through 2-4 simulated scenarios using high-fidelity simulation. In the intervention group, these scenarios will be sepsis syndrome scenarios. In the control group, non-sepsis scenarios will be administered.

Immediately following the scenarios, a written knowledge quiz focusing on recognition and management of sepsis will be administered to subjects in both groups.

Following the quiz, there will be a debrief session for subjects in both groups of the simulation scenarios, pointing out what was done correctly and what was not.

There will then be a brief didactic teaching session focusing on recognition and management of sepsis administered to subjects in both groups.

2-4 months later, subjects in both groups will be brought back to the simulation lab and tested on a new identical set of simulated sepsis scenarios. This will be videotaped and scored by an impartial volunteer who will score performance according to a check-list of critical actions. Following the simulated scenarios, the written quiz administered at the first visit will be given again. Subjects in both groups will then get debriefed on their performance.

Data can then be compared between the control and intervention group in terms of written and practical performance. Other potential analyses include before and after performance in the intervention group, comparison between the intervention and control groups, as well as subanalysis by PGY level. Student's paired and unpaired t-test will be the model for statistical analysis, and the investigators will utilize a statistician for data analysis.

In developing and implementing a multi-modality sepsis teaching curriculum, and demonstrating its superiority to a didactic-only curriculum, the investigators hope to justify the permanent implementation of a multi-modality teaching module to educate residents (and other healthcare personnel) which will lead to improved recognition and management of sepsis and improved patient outcomes.

Being tested
Debriefing of high-fidelity sepsis simulation scenarios, Placebo: Debriefing of high-fidelity non-sepsis simulation scenarios
Keywords
Simulation, Sepsis, High-fidelity, Severe Sepsis, Septic Shock, Education
Medical subject headings
Sepsis, Shock, Septic

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Debriefing of high-fidelity sepsis simulation scenariosOther

    Also called Education, High-fidelity simulation, Debriefing

    Educational intervention

  • Placebo: Debriefing of high-fidelity non-sepsis simulation scenariosOther

Study groups in NCT01992120
Study groupRoleWhat they receive
Debriefing of high-fidelity sepsis simulation scenariosExperimentalFirst visit: * Subjects will fill out a self-assessment focusing on perceptions of their knowledge and ability in the recognition and management of sepsis in hospitalized patient * Subjects will be specifically exposed to high-fidelity simulated sepsis scenarios and be debriefed on their performance in these scenarios (intervention) * Subjects will take a written test focusing on early recognition and management of sepsis * Subjects will receive a didactic teaching session focusing on recognition and management of early sepsis in the hospitalized patient In the second visit: * Subjects will be exposed to a number of high-fidelity simulated sepsis scenarios and be scored on their performance in management of these scenarios * Subjects will take a written test of knowledge focusing on early recognition and management of sepsis * Subjects will then be debriefed specifically on their performance in the simulation scenarios
Receives: Other: Debriefing of high-fidelity sepsis simulation scenarios
Debriefing of high-fidelity non-sepsis simulation scenariosPlacebo comparatorFirst visit: * Subjects will fill out a self-assessment survey of their perceptions of their knowledge and ability in the recognition and management of sepsis in the hospitalized patient * Subjects will be exposed to high-fidelity simulation scenarios (non-sepsis) and be debriefed in terms of their performance in these scenarios * Subjects will take a written test of knowledge focusing on early recognition and management of sepsis * Subjects will receive a didactic teaching session focusing on recognition and management of early sepsis in the hospitalized patient In the second visit: * Subjects will be exposed to a number of high-fidelity simulated sepsis scenarios and be scored on their performance in management of the scenarios * Subjects will take a written test of knowledge focusing on early recognition and management of sepsis * Subjects will then be debriefed specifically on their performance in the simulation scenarios
Receives: Other: Placebo: Debriefing of high-fidelity non-sepsis simulation scenarios

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Performance on a written assessment of the recognition and management of early sepsis in the hospitalized patient.

    Written test

    Measured: 2-4 months after intervention

  2. Performance on a practical assessment of the recognition and management of early sepsis in the hospitalized patient.

    Graded performance in simulated sepsis scenario utilizing high-fidelity simulation

    Measured: 2-4 months after intervention

Secondary outcomes (1)
  1. Self-assessment of knowledge and ability in the recognition and management of early sepsis in the hospitalized patient.

    Written self-assessment survey

    Measured: 2-4 months after intervention

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted25 Nov 2013 (estimated)
  2. Study startNov 2013
  3. Primary completionJul 2014
  4. Study completionJul 2014

Why it stopped: Key Personnel left institution

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Allocation
Randomised
Intervention model
Parallel groups
Masking
Single blind
Who is masked
Participant
Enrolment
40 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT01992120
Sponsor's protocol ID
VA01419
Status last verified
Dec 2015
First submitted
30 Oct 2013
Last updated
8 Dec 2015
Results posted
No
Data monitoring committee
No

Questions about this trial

What is this clinical trial studying?

A study testing Debriefing of high-fidelity sepsis simulation scenarios in people with Medical Knowledge and Clinical Performance, run by NYU Langone Health at 1 site in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 1 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: stopped early, as of the sponsor's last update on 8 Dec 2015. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. Some participants in this study may receive a placebo. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study was stopped early (reason given: Key Personnel left institution). Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Performance on a written assessment of the recognition and management of early sepsis in the hospitalized patient. (time frame: 2-4 months after intervention). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 8 Dec 2015.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in